These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3370192)

  • 1. The effect of probenecid on the renal tubular excretion of benzylpenicillin.
    Overbosch D; Van Gulpen C; Hermans J; Mattie H
    Br J Clin Pharmacol; 1988 Jan; 25(1):51-8. PubMed ID: 3370192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.
    Verhagen CA; Mattie H; Van Strijen E
    Br J Clin Pharmacol; 1994 Feb; 37(2):193-7. PubMed ID: 8186065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturation of the tubular excretion of beta-lactam antibiotics.
    Bins JW; Mattie H
    Br J Clin Pharmacol; 1988 Jan; 25(1):41-50. PubMed ID: 3370191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tubular excretion of benzylpenicillin in patients with cystic fibrosis.
    Bins JW; Mattie H
    Br J Clin Pharmacol; 1989 Mar; 27(3):291-4. PubMed ID: 2719893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
    Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active transport of benzylpenicillin across the blood-milk barrier.
    Schadewinkel-Scherkl AM; Rasmussen F; Merck CC; Nielsen P; Frey HH
    Pharmacol Toxicol; 1993 Jul; 73(1):14-9. PubMed ID: 8234185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of renal tubular transport of methotrexate by probenecid.
    Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
    Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tubular secretion and effects of furosemide.
    Odlind B; Beermann B
    Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of probenecid on plasma/tissue distribution of 14C-benzylpenicillin in rats.
    Bergholz H; Erttmann RR; Damm KH
    Experientia; 1980 Mar; 36(3):333-4. PubMed ID: 7371792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.
    Wang C; Wang C; Liu Q; Meng Q; Cang J; Sun H; Peng J; Ma X; Huo X; Liu K
    Drug Metab Dispos; 2014 Jun; 42(6):996-1007. PubMed ID: 24692216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubular mechanisms determining the urinary excretion of tritiated prostaglandin E2 in the anaesthetized rat.
    Haylor J; Lote CJ; Towers JD
    J Physiol; 1988 Sep; 403():1-14. PubMed ID: 3253420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal handling of captopril: effect of probenecid.
    Sinhvi SM; Duchin KL; Willard DA; McKinstry DN; Migdalof BH
    Clin Pharmacol Ther; 1982 Aug; 32(2):182-9. PubMed ID: 7047044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs.
    Kim SH; Kim WB; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):85-92. PubMed ID: 9755846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a postsecretory reabsorptive site for uric acid in man.
    Diamond HS; Paolino JS
    J Clin Invest; 1973 Jun; 52(6):1491-9. PubMed ID: 4703233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous kinetic modelling of plasma levels and urinary excretion of salicyluric acid, and the influence of probenecid.
    Hekman P; van Ginneken CA
    Eur J Drug Metab Pharmacokinet; 1983; 8(3):239-49. PubMed ID: 6653616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal handling of the monobactam azthreonam in healthy subjects.
    Swabb EA; Sugerman AA; Frantz M; Platt TB; Stern M
    Clin Pharmacol Ther; 1983 May; 33(5):609-14. PubMed ID: 6682362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of probenecid on the pharmacokinetics of ceftizoxime.
    LeBel M; Paone RP; Lewis GP
    J Antimicrob Chemother; 1983 Aug; 12(2):147-55. PubMed ID: 6311785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3902-7. PubMed ID: 19564368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit.
    Hedaya MA; Sawchuk RJ
    J Pharm Sci; 1989 Sep; 78(9):716-22. PubMed ID: 2585262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.